Drug Information for INCRELEX™ (mecasermin [rDNA origin] injection) (Tercica, Inc.): CONTRAINDICATIONS

  • INCRELEX™ should not be used for growth promotion in patients with closed epiphyses.

    INCRELEX™ is contraindicated in the presence of active or suspected neoplasia, and therapy should be discontinued if evidence of neoplasia develops.

    Intravenous administration of INCRELEX™ is contraindicated.

    INCRELEX™ should not be used by patients who are allergic to mecasermin (IGF-1) or any of the inactive ingredients in INCRELEX™.

  • Drug Information Provided by National Library of Medicine (NLM).